| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Medpace Holdings, Inc.
13D/A
MEDP · 58506Q109
|
19.1% |
9/28/2026
Event 9/24/2026
|
||||
| August J. Troendle | 19.1% | |||||
| Medpace Investors, LLC | 16.8% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.